Cleveland Clinic Educational Seminar: Living with Chronic Disease
source: pixabay.com

Cleveland Clinic Educational Seminar: Living with Chronic Disease

On March 11, 2021, Patient Worthy attended an educational seminar hosted by the Cleveland Clinic titled Neuromyelitis Optica Spectrum Disorder (NMOSD): Educational Seminar for Patients, Family Members and Caregivers Focus…

Continue Reading Cleveland Clinic Educational Seminar: Living with Chronic Disease
Study Finds That Neuromyelitis Optica Patients Could Face Weakened Bones and Fractures
source: pixabay.com

Study Finds That Neuromyelitis Optica Patients Could Face Weakened Bones and Fractures

According to a story from Neurology Advisor, a recent study has found that patients living with neuromyelitis optica spectrum disorder (NMOSD) are at an increased risk of experiencing bone loss,…

Continue Reading Study Finds That Neuromyelitis Optica Patients Could Face Weakened Bones and Fractures
Satralizumab May Lower Neuromyelitis Optica Spectrum Disorder Relapse in Patients
source: pixabay.com

Satralizumab May Lower Neuromyelitis Optica Spectrum Disorder Relapse in Patients

By Danielle Bradshaw from In The Cloud Copy It has been shown in a recently published trial that satralizumab could potentially reduce the risk of neuromyelitis optica spectrum disorder (NMOSD)…

Continue Reading Satralizumab May Lower Neuromyelitis Optica Spectrum Disorder Relapse in Patients
Marketing Applications for a Possible Neuromyelitis Optica Spectrum Disorder Drug Have Been Accepted in the US and EU
LhcCoutinho / Pixabay

Marketing Applications for a Possible Neuromyelitis Optica Spectrum Disorder Drug Have Been Accepted in the US and EU

According to a story from BioSpace, Chugai Pharmaceutical Co., Ltd. has recently announced that the Marketing Authorisation Application for the its drug satralizumab has been accepted by the European Medicines…

Continue Reading Marketing Applications for a Possible Neuromyelitis Optica Spectrum Disorder Drug Have Been Accepted in the US and EU